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Hyperactivation of the hypothalamo-pituitary-adrenocortical
axis in streptozotocin diabetic rats: effect of
Tinospora cordifolia (Willd.) and insulin therapy
Nagaraja PURANIK1, Sheela DEVI DEVI2, Kararshaha KAMMAR1

Aim: In the present study, we investigated the extent to which changes in corticosterone level and food and water intake
behavior occur in diabetes and explored the effect of Tinospora cordifolia extracts and insulin therapy in streptozotocininduced diabetic rats.
Materials and methods: Female albino rats of the inbred Wistar strain (body weight: 180-210 g) were used in this
study. Experimental diabetes was induced by injecting freshly prepared streptozotocin once at the dose of 55 mg/kg
body weight intravenously in 0.1 M citrate buffer, pH 4.5. The drug was administered orally for 10 days and 30 days in
different groups containing 6 rats in each group. Body weight, food intake, and water intake were monitored in each
animal. Fasting blood glucose and plasma corticosterone levels were estimated. The efficacy of this drug was compared
with lente zinc insulin (6 units/kg body weight daily, intraperitoneally) in treating diabetic rats.
Results: There was a striking reduction in body weight, but elevated fasting blood glucose and corticosterone levels were
observed in untreated diabetic rats during the study period. Elevated water and food intake was also prominent in these
animals. Treatment with Tinospora cordifolia as well as insulin therapy could ameliorate all of these altered parameters
toward normal.
Conclusion: This study clearly showed that Tinospora cordifolia has a significant (P < 0.05) effect in ameliorating all of
these parameters toward normal in diabetic animals and has a level of efficacy that is considerably good compared to
standard drug insulin.
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Introduction
Increased hypothalamo-pituitary-adrenal (HPA)
activity in patients with diabetes mellitus (DM) has
been reported and is especially prevalent in those
individuals with poor glycemic control or ketoacidosis
(1,2). However, the mechanism underlying the
hyperactivation of the HPA axis in diabetes remains
unclear. Increased HPA function in type 1 and type
2 diabetic patients and animals is characterized
by elevated circulating cortisol or corticosterone
levels. Moreover, diabetic patients exhibit disrupted

circadian patterns of cortisol secretion, with elevated
cortisol levels in the course of nadir and normal
secretion or slightly elevated values during peak
secretion (2,3). Hyperglycemia, loss of body weight,
and changes in feeding and drinking behavior are
also seen in DM (4). No satisfactory studies have
been conducted thus far to reveal the extent of
these changes in diabetic animals or to investigate
the effect of herbal drug Tinospora cordifolia and
insulin therapy on these altered parameters. Thus,
this study was undertaken to investigate the extent of
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HPA axis hyperactivation in terms of corticosterone
secretion in streptozotocin-induced diabetic rats
and to explore the effect of herbal drug Tinospora
cordifolia and insulin therapy on it. The effects of
these drugs on other associated changes in diabetes,
such as reduction in body weight and elevated food
and water intake, were also investigated in this study.
Tinospora cordifolia (Willd.) Miers ex Hook.f. &
Thoms (TC) belongs to the family Menispermaceae
and is known as Gulancha in English, Guduchi in
Sanskrit, and Giloya in Hindi. It is a large, glabrous,
deciduous climbing succulent shrub, commonly
found in hedges. It has been long known in Ayurvedic
literature as a tonic, a vitalizer, and a remedy for
diabetes and other metabolic disorders (5). In the
present study, we have used the aqueous and alcoholic
extracts of Tinospora cordifolia in different dosages to
reveal its effect on experimental DM.
Materials and methods
Plant material
Tinospora cordifolia stem was collected fresh from
forest areas in the Udupi district of Karnataka state,
India, and then dried in the shade and powdered.
The plant was identified by Mangala Gangothri,
Professor and Head of the Department of Botany,
Mangalore University. A specimen (Voucher No. 31)
was deposited in the botany department museum of
the university. The powdered materials were kept in
an air-tight container in a refrigerator until the time
of use.
Extraction
Aqueous and alcoholic extracts of TC were prepared
according to the standard extract procedure (6). A
known volume of TC dried powder was processed
with water and alcohol separately. The yield of the
extracts was approximately 8.5% and 7%, respectively.
Animals and time of experiment
As per the literature, albino rats of both sexes can be
used for experimental DM. Thus, female albino rats of
the inbred Wistar strain (body weight [b.w.]: 180-210
g) were used in this study. Animal ethical committee
clearance was obtained from the Institutional Animal
Ethics Committee (IACE No. 08/004/02). The animals
were fed on pellet diet (Hindustan Lever Ltd., India)
and water ad libitum throughout the study period.

All experiments were carried out between 0800 and
1000 hours in order to avoid changes induced by the
circadian rhythm.
Experimental induction of diabetes
To induce diabetes, the rats were fasted for 16 h and
injected with freshly prepared streptozotocin (STZ;
Sigma Chemicals, USA) at the dose of 55 mg/kg
b.w. intravenously (7) in 0.1 M citrate buffer, pH 4.5.
Control animals received citrate buffer alone.
Diabetes status was confirmed by estimating
the fasting blood glucose levels and urine glucose
(Benedict’s test) 72 h after STZ injection. Diabetic
animals showing fasting blood glucose levels above
250 mg/dL were selected for this study.
Experimental protocol
All of the experimental animals were divided into 7
groups with each group consisting of 6 animals as
follows:
Group 1 - Control; this group was used for
studying the baseline values of the parameters
studied.
Group 2 - Diabetic control; this group consisted
of STZ-induced diabetic rats.
Group 3 - Diabetic rats treated with 200 mg/kg
b.w. aqueous extract of TC.
Group 4 - Diabetic rats treated with 400 mg/kg
b.w. aqueous extract of TC.
Group 5 - Diabetic rats treated with 200 mg/kg
b.w. alcoholic extract of TC.
Group 6 - Diabetic rats treated with 400 mg/kg
b.w. alcoholic extract of TC.
Group 7 - Diabetic rats treated with insulin.
Neither of these solvents interferes with normal
parameters in any way, which was evident in our pilot
study. Therefore, no separate control group for either
solvent was included in this study. Animals were kept
in a metabolic cage and provided with a measured
volume of water in the bottle and a known amount of
powdered food in the food tray to avoid the spilling
of pellet as fragments. After 24 h, the amount of food
consumed was measured. Similarly, the water intake
was monitored by considering the water remaining
in the bottle. The body weight of each individual
animal was monitored daily.
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Drug treatment
A single dosage of either aqueous extract (dissolved
in normal saline) or alcoholic extract (dissolved in
gum acacia) (6) was given orally for 10 days and 30
days to specific groups through oral intubations, and
the control animals received the vehicle alone.

EIA Kit, Biogenuix, India). The efficacy of TC was
measured by a simple calculation in which the
drug or insulin returning a particular parameter to
the original normal value was considered as 100%
efficacious. Accordingly, the efficacy for the drug or
insulin was calculated.

Ten-day and 30-day treatment signifies that 1
group received the given drug for 10 days while
another group received it for 30 days. Lente zinc
insulin (6 units/kg b.w. intraperitoneally) was given to
a specific group daily (8). TC drug extract was given
orally. Since insulin cannot be given orally as it is a
protein in nature, it was given via the intraperitoneal
route.

Statistics analysis

At the end of the experimental period, animals
were killed by cervical decapitation. Blood and plasma
samples were collected after 12 h of fasting. Fasting
blood glucose was measured by the glucose-oxidase
method (9). Plasma corticosterone was measured by
the corticosterone ELISA kit method (Corticosterone

In the present study, we investigated the plasma
corticosterone levels, changes in body weight, and
changes in food and water intake in TC-treated
diabetic and untreated diabetic animals, and we
compared the efficacy of TC treatment with that
of insulin treatment. The plasma corticosterone

Statistical significance between the different groups
was determined by one-way analysis of variance
(ANOVA) followed by Tukey’s multiple comparisons
by fixing the P-value as P < 0.05.
Results

Table 1. Effect of TC on plasma corticosterone (μg/dL) and body weight (g).

Plasma
corticosterone
(μg/dL)

Diabetic +
200 mg/kg
b.w. aqueous
extract

Diabetic +
Diabetic +
Diabetic +
400 mg/kg
200 mg/kg
400 mg/kg
b.w. aqueous b.w. alcoholic b.w. alcoholic
extract
extract
extract

Diabetic +
insulin

Days

Control

Diabetic
control

Day 11

41.28 ± 4.0

*
71.65 ± 2.4

*a
58.85 ± 3.1

*a
61.92 ± 3.3

* a
63.29 ± 3.5

*a
61.60 ± 3.6

46.10 ± 2.7

Day 31

39.07 ± 2.4

*
98.77 ± 3.6

*a
63.59 ± 2.8

*a
66.05 ± 3.3

*a
66.96 ± 3.5

*a
62.73 ± 2.0

*
50.64 ± 2.1

Day 11

-

-

42.14

32.03

27.52

33.09

84.12

Day 31

-

-

58.92

54.80

53.28

60.36

80.61

Day 11

190.00 ± 12.6

*
*a
*a
142.50 ± 4.1 160.00 ± 10.9 164.17 ± 4.9

*a
161.67 ± 4.0

*a
163.33 ± 5.1

184.17 ± 3.7

Day 31

202.50 ± 4.1

*
*a
*a
136.67 ± 5.1 160.00 ± 10.9 163.33 ± 5.1

*a
161.67 ± 4.0

*a
*
165.00 ± 5.4 183.33 ± 5.1

Day 11

-

-

36.84

45.6

40.33

43.85

87.70

Day 31

-

-

35.54

40.50

37.97

43.04

70.88

Efficacy
(%)

Body weight
(g)

Efficacy
(%)

Data are expressed as mean ± standard deviation, n = 6. *P < 0.05 for control versus other groups; aP < 0.05 for diabetic control versus
TC-treated diabetic groups.
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Table 2. Effect of TC extracts on fasting blood glucose (mg/dL) and comparison of efficacy of TC extracts with insulin. Values are
expressed in % amelioration toward normal levels.

Fasting blood
glucose
(mg/dL)

Diabetic
control

Diabetic +
200 mg/kg
b.w. aqueous
extract

Diabetic +
Diabetic +
Diabetic +
400 mg/kg
200 mg/kg
400 mg/kg
b.w. aqueous b.w. alcoholic b.w. alcoholic
extract
extract
extract

Diabetic +
insulin

Days

Control

Day 11

89.17 ± 5.1

*
*a
*a
353.24 ± 4.5 162.68 ± 12.7 221.74 ± 5.2

*a
196.45 ± 5.6

*a
215.57 ± 4.4

*
126.21 ± 2.8

Day 31

89.60 ± 2.5

*
346.97 ± 5.5

*a
190.69 ± 6.5

*a
236.87 ± 3.0

*a
228.90 ± 2.9

*a
214.27 ± 2.9

*
138.20 ± 2.1

Day 11

-

-

72.16

49.79

59.37

52.13

85.97

Day 31

-

-

60.72

42.77

45.87

51.56

81.11

Efficacy
(%)

Data are expressed as mean ± standard deviation, n = 6. *P < 0.05 for control versus other groups; aP < 0.05 for diabetic control versus
TC-treated diabetic groups.

levels increased significantly in the diabetic animals
during the study period (Table 1). Treatment with
TC and insulin in diabetic rats for 10 days and 30
days could decrease the plasma corticosterone levels
effectively. However, the corticosterone level was not
normalized with any one of the treatments. Elevated
glucose levels (Table 2) were also observed in these
TC-treated animals.

Discussion

in blood glucose levels by the action of insulin on
the other hand. Absence or deficiency of insulin
leads to an alteration in glucose homeostasis, which
results in DM. Previous studies have reported that
DM represents a sustained stimulus to the HPA axis
during the nadir of circadian activity. It is said that
HPA hyperdrive in diabetes is partially mediated
by decreased glucocorticoid negative feedback
sensitivity (10). Therefore, it is a well-known fact
that uncontrolled DM results in increased circulating
glucocorticoid levels (11). It was reported that the
plasma corticosterone levels were elevated 5-fold in
untreated STZ-diabetic rats; in insulin-implanted
diabetic animals, the levels were not different from
the control levels (4). In the present study, the plasma
corticosterone levels were increased significantly in
diabetic rats during the study period (Table 1). This
elevation in corticosteroid levels may be another
contributing factor for an elevated glucose level in
diabetic rats (Table 2), since corticosteroids interfere
with the glucose uptake and utilization in extrahepatic
tissues (12). Treatment with TC and insulin in
diabetic rats for 10 days and 30 days could decrease
the plasma corticosterone levels effectively.

Glucose homeostasis in the body depends on a
balance between multihormonal enhancements of
blood sugar levels (catecholamines, glucocorticoids,
growth hormones, etc.) on one hand and diminution

Reduction in body weight is seen in untreated
DM in spite of increased food intake. Much literature
supports the hypothesis that the reduced signaling by
insulin or leptin, as would occur in untreated diabetes,

Body weight in untreated diabetic rats decreased
significantly during the study period (Table 1).
Treatment with TC for 10 and 30 days could protect
the diabetic rats from further decrease in body weight,
and body weight was significantly increased. Water
and food intake in untreated diabetic rats increased
significantly during the study period (Table 3).
Treatment with TC could decrease the water intake
and food intake in the diabetic animals. However,
these parameters were not normalized even after
TC treatment. Insulin treatment, meanwhile, could
normalize these changes in food and water intake
behavior.
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Table 3. Effect of TC on food intake (g/day) and water intake (mL/day)
Diabetic +
200 mg/kg
b.w. aqueous
extract

Diabetic +
Diabetic +
Diabetic +
400 mg/kg
200 mg/kg
400 mg/kg
b.w. aqueous b.w. alcoholic b.w. alcoholic
extract
extract
extract

Control

Diabetic
control

12.1 ± 1.2

*
29.1 ± 2.0

*a
23.1 ± 2.4

*a
24.4 ± 2.0

*a
23.3 ± 3.3

*a
23.1 ± 2.3

15.7 ± 0.7

13.5 ± 1.8

*
35.3 ± 2.2

*a
26.8 ± 1.5

*a
25.4 ± 4.0

*a
27.7 ± 1.9

*a
23.8 ± 1.9

16.1 ± 0.6

Day 11

-

-

35.29

27.64

34.11

35.29

78.82

Day 31

-

-

38.99

45.41

34.86

52.75

88.07

18.3 ± 3.7

*
90.8 ± 2.5

*a
71.6 ± 2.0

*a
72.5 ± 2.0

*a
74.6 ± 2.0

*a
66.9 ± 2.0

*
33.8 ± 2.8

19.6 ± 3.0

*
94.7 ± 2.5

*a
64.6 ± 2.8

*a
71.9 ± 3.2

*a
64.7 ± 1.0

*a
60.4 ± 2.9

*
34.7 ± 3.1

Day 11

-

-

26.48

25.24

22.34

32.96

78.62

Day 31

-

-

40.07

30.35

39.94

45.67

79.89

Days

Day 11
Food intake
(g/day)
Day 31

Diabetic +
insulin

Efficacy
(%)

Day 11
Water intake
(mL/day)
Day 31

Efficacy
(%)

Data are expressed as mean ± standard deviation, n = 6. *P < 0.05 for control versus other groups; aP < 0.05 for diabetic control versus
TC-treated diabetic groups.

stimulates the feeding behavior via changes in the
activities of hypothalamic neuropeptide-containing
pathways. It was reported that the STZ-treated
diabetic rats lost 10 g of body weight within 7 days
of the induction of diabetes, whereas nondiabetic
animals gained 31 g during that period (4). Weight
loss in diabetic animals may be due to the increased
protein catabolism or altered fat metabolism seen in
the diabetic state.
In the present study, the body weight in untreated
diabetic rats decreased significantly during the
study period (Table 1). Treatment with TC for 10
and 30 days could protect the diabetic rats from
further decrease in body weight, and body weight
was significantly increased. This may be due to the
fact that the TC prevented protein catabolism or
improved lipid metabolism (13). In the present study,
treatment with insulin could maintain and normalize
the body weight in diabetic rats.
1080

The water intake and food intake in untreated
diabetic rats increased significantly during the study
period (Table 3).
These behavioral changes may be due to the
dehydration caused by hyperglycemia resulting in
glycosuria and osmotic diuresis, and also due to
disinhibited activity of the feeding center. Similar
observations in diabetic rats were reported earlier
(14). Treatment with TC could decrease the water
intake and food intake in diabetic rats significantly,
but these were not normalized even after the TC
treatment, possibly due to the fact that TC treatment
did not normalize the higher levels of blood glucose
in these animals. Insulin treatment could normalize
these changes in food and water intake behavior.
This study concludes that treatment with
Tinospora cordifolia and insulin could ameliorate the
body weight, behavioral changes in food and water
intake, and increased corticosterone levels caused
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due to hyperactivation of the HPA axis in diabetic
animals. The efficacy of these effects was considerably
good compared to insulin, although efficacy was
not related to the dosage, duration of treatment, or
type of extract. This study reveals the usefulness and
therapeutic value of Tinospora cordifolia as an herbal
drug in treating DM.
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